Phase Ib/II Trial Of Envafolimab, A Novel Subcutaneous Single-Domain Anti-Pd-L1 Monoclonal Antibody, Plus Lenvatinib In Patients With Selected Advanced Solid Tumors
Envafolimab;Lenvatinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase Ib/II Trial Of Envafolimab, A Novel Subcutaneous Single-Domain Anti-Pd-L1 Monoclonal Antibody, Plus Lenvatinib In Patients With Selected Advanced Solid Tumors ### Output: Envafolimab;Lenvatinib